Patents Assigned to Bayer
  • Patent number: 7156052
    Abstract: An enclosure is provided having openings for allowing entry of rodents into the enclosure. There is arranged one or more applicators in the form of a suspended flexible web configured to contact rodents entering the chamber and having a chemical on the web for application to the rodents.
    Type: Grant
    Filed: October 21, 2003
    Date of Patent: January 2, 2007
    Assignees: Bayer Crop Science SA, Center for Disease Control and Prevention, Band G Equipment Company
    Inventors: Gary O. Maupin, Marc C. Dolan, Nicholas Hamon, Eric J. Snell
  • Patent number: 7157063
    Abstract: Process wherein the vanadium present in the chromium ore chromite is recovered as vanadium pentoxide during the course of the fusion of the chromium ore with alkali and its work-up to produce sodium chromate solution and sodium dichromate.
    Type: Grant
    Filed: April 1, 2003
    Date of Patent: January 2, 2007
    Assignee: Bayer Aktiengesellschaft
    Inventors: Rainer Weber, Hans-Dieter Block, Michael Batz, Jost Halstenberg, Michael Lumm, Roland-Luiz Roth, Dawie Van Der Merre
  • Patent number: 7157481
    Abstract: Novel isothiazolecarboxamides of the formula in which R is as defined in the description, a plurality of processes for preparing the novel compounds and their use for protecting plants against attack by undesirable microorganisms and animal pests.
    Type: Grant
    Filed: December 22, 2004
    Date of Patent: January 2, 2007
    Assignee: Bayer Aktiengesellschaft
    Inventors: Lutz Assmann, Dietmar Kuhnt, Hans-Ludwig Elbe, Christoph Erdelen, Stefan Dutzmann, Gerd Hänssler, Klaus Stenzel, Astrid Mauler-Machnik, Yoshinori Kitagawa, Haruko Sawada, Haruhiko Sakuma
  • Publication number: 20060293322
    Abstract: The present invention relates to a compound of Formula (I) and its use in treating hyper-proliferative disorders.
    Type: Application
    Filed: July 23, 2004
    Publication date: December 28, 2006
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Chengzhi Zhang, Gaetan Ladouceur, Catherine Brennan, Brent Chandler, Julie Dizon, Karl Miranda, Dongping Fan, Qingming Zhu, Sharad Verma, Jacques Dumas
  • Patent number: 7154592
    Abstract: A readhead for use in the determination of the concentration of an analyte in a sample comprises a read area for receiving the sample, a light source including a plurality light emitting elements for outputting light at a plurality of wavelengths, a light guide having an input end and an output end, a lens for receiving light from the output end of the light guide and for illuminating the sample with a substantially collimated beam of light, and a detector for detecting light from the sample in response to illuminating the sample. The input end of the light guide being optically coupled to the light source for receiving light output by the plurality of light emitting elements. The input end of the light guide has a center that is offset from the center of at least one of the plurality of light elements. The light guide guides a substantial portion of the light received from the light source to the output end of the light guide.
    Type: Grant
    Filed: February 2, 2004
    Date of Patent: December 26, 2006
    Assignee: Bayer Healthcare LLC.
    Inventors: Jeffery S. Reynolds, Andrew J. Dosmann
  • Patent number: 7153813
    Abstract: The invention relates to novel substituted aryl ketones of the formula (I) in which Z, X, R and n are as defined in the disclosure, to processes for their preparation and to their use as crop treatment agents, and to intermediates for preparing compounds of the formula (I).
    Type: Grant
    Filed: February 12, 2003
    Date of Patent: December 26, 2006
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Georg Schwarz, Mark Wilhelm Drewes, Peter Dahmen, Dieter Feucht, Rolf Pontzen, Monika Schmitt
  • Patent number: 7153929
    Abstract: Rubber-free copolymers of unsaturated monomers selected from the group comprising styrenes and vinyl cyanides are disclosed. The copolymers that contain 65 to 80 wt. %, of styrene and 20 to 35 wt. % of acrylonitrile are characterized in their low content of residual monomers and improved physical properties. Also disclosed are a process and a device for the preparation of these copolymers.
    Type: Grant
    Filed: June 18, 2001
    Date of Patent: December 26, 2006
    Assignee: Bayer Aktiengesellschaft
    Inventors: Alfred Eitel, Klemens Kohlgrüber, Frank Weyrich, Peter Rudolph, Hans-Jürgen Thiem, Michael König, Ricarda Nothelle, Helmut Meyer
  • Patent number: 7154006
    Abstract: The invention relates to a process for preparing fluorinated anilines starting from the corresponding chlorinated anilines, and also to the use of the fluorinated anilines.
    Type: Grant
    Filed: October 14, 2004
    Date of Patent: December 26, 2006
    Assignee: Bayer Aktiengesellschaft
    Inventors: Mark Mikulas, Albrecht Marhold
  • Publication number: 20060287315
    Abstract: The present invention relates to novel pyridinedicarboxamides, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular thromboembolic disorders.
    Type: Application
    Filed: December 8, 2005
    Publication date: December 21, 2006
    Applicant: Bayer HealthCare AG
    Inventors: Susanne Rohrig, Mario Jeske, Metin Akbaba, Ulrich Rosentreter, Stephen Boyer, Karin Fischer, Jens Pohlmann, Arounarith Tuch, Elisabeth Perzborn, Christoph Gerdes, Karl-Heinz Schlemmer, Nils Burkhardt, Swen Allerheiligen, Peter Nell, Sabine Arndt, Mario Lobell
  • Publication number: 20060287305
    Abstract: This invention relates to the use of certain C-10 substituted derivatives of artemisinin of general formula (I) in the treatment and/or prophylaxis of diseases caused by infection with a parasite, certain novel C-10 substitued derivatives of artemisinin, processes for their preparation and pharmaceutical compositions containing such C-10 substituted derivatives. The compounds are particularly effective in the treatment of malaria, neosporosis and coccidiosis.
    Type: Application
    Filed: January 9, 2006
    Publication date: December 21, 2006
    Applicant: Bayer Aktiengesellschaft
    Inventors: Richard Haynes, William Lam, Ho-Wai Chan, Hing-Wo Tsang, Man-Ki Cheung, Gisela Greif, Gabriele Schmuck, Arnd Voerste
  • Publication number: 20060287453
    Abstract: The invention relates to a phosphorus-containing polymer for coating dielectric materials, to processes for its preparation and to its use, as well as to an optical signal transducer having a coating of the polymer and to its use.
    Type: Application
    Filed: August 21, 2006
    Publication date: December 21, 2006
    Applicant: BAYER AKTIENGESELLSCHAFT
    Inventors: Ingmar Dorn, Burkhard Kohler
  • Publication number: 20060287387
    Abstract: This invention relates to a novel fused tricyclic heterocycle of the formula and its use for the treatment of hyper-proliferative disorders.
    Type: Application
    Filed: August 28, 2006
    Publication date: December 21, 2006
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Chengzhi Zhang, Michael Burke, Zhi Chen, Jacques Dumas, Dongping Fan, Benjamin Jones, Gaetan Ladouceur, Wendy Lee, Barton Phillips, Scott Wilhelm, Qian Zhao
  • Patent number: 7151151
    Abstract: A method of dimerizing isocyanates including reacting the isocyanates in the presence of phosphines containing at least one directly phosphorus-attached bicyclic, cycloaliphatic radical. The polyisocyanate compositions obtained as described above can be used in mouldings, coating materials, adhesives, sealants or adjuvants that further include the polyisocyanate compositions and one or more materials selected from antioxidants, light stabilizers, pigments, fillers, additives, levelling assistance, defoamers and matting agents. The coating materials, adhesives or sealants can be used to coat substrates.
    Type: Grant
    Filed: November 17, 2004
    Date of Patent: December 19, 2006
    Assignee: Bayer MaterialScience AG
    Inventors: Frank Richter, Reinhard Halpaap, Hans-Josef Laas, Andreas Hecking
  • Patent number: 7151265
    Abstract: A chopped radiation source composed of a radiation source component, a chopping component and an optical fiber connector component. Each of these components is arranged within a housing in a manner such that the elements of each of these components will not move in an unintended manner during use.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: December 19, 2006
    Assignee: Bayer Materialscience LLC
    Inventors: Robert Nathan Hunt, Atul Khettry, Matthew Rey Vila
  • Patent number: 7151195
    Abstract: The present invention relates to a phthalamide derivative represented by the general formula (I): wherein R1, R2, R3, X, Y, m, and n are as defined in the disclosure, which can be used as the active ingredient in an agricultural or horticultural insecticide that exhibits an excellent insecticidal effect even when used in a small active-ingredient amount.
    Type: Grant
    Filed: May 1, 2003
    Date of Patent: December 19, 2006
    Assignee: Bayer CropScience LP
    Inventors: Yoshihiro Matsuzaki, Masayuki Morimoto, Shinsuke Fujioka, Masanori Tohnishi
  • Patent number: 7150976
    Abstract: Reagents which regulate human serine-threonine protein kinase and reagents which bind to human serine-threonine protein kinase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, CNS disorders, diabetes, and COPD.
    Type: Grant
    Filed: October 16, 2001
    Date of Patent: December 19, 2006
    Assignee: Bayer HealthCare AG
    Inventor: Zhimin Zhu
  • Publication number: 20060281767
    Abstract: The invention relates to new triazolopyrimidines of the formula in which R1, R2, R3, G and X have the meanings given in the description, a process for preparing these substances and their use for combating undesirable micro-organisms. The invention further relates to new intermediate products of the formulae and processes for preparing these substances.
    Type: Application
    Filed: June 14, 2004
    Publication date: December 14, 2006
    Applicant: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    Inventors: Olaf Gebauer, Ulrich Heinemann, Jorg Greul, Stefan Herrmann, Oliver Guth, Hans-Ludwig Elbe, Herbert Gayer, Stefan Hillebrand, Ulrike Wachendorff-Neumann, Karl-Heinz Kuck, Peter Dahmen
  • Publication number: 20060281085
    Abstract: The invention provides a human PDE1B which is associated with the cardiovascular disorders, metabolic diseases, gastrointestinal and liver diseases, cancer disorders, hematological disorders, respiratory diseases, neurological disorders and urological disorders. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular disorders, metabolic diseases, gastrointestinal and liver diseases, cancer disorders, hematological disorders, respiratory diseases, neurological disorders and urological disorders. The invention also features compounds which bind to and/or activate or inhibit the activity of PDE1B as well as pharmaceutical compositions comprising such compounds.
    Type: Application
    Filed: February 27, 2004
    Publication date: December 14, 2006
    Applicant: Bayer Healthcare AG
    Inventors: Stefan Golz, Ulf Bruggemeier, Andreas Geerts
  • Patent number: 7148277
    Abstract: Water-containing compositions containing polychloroprene particles, zinc oxide particles having an average particle size of less than 150 nm and water. The compositions can be used as adhesives and/or sealants.
    Type: Grant
    Filed: May 28, 2004
    Date of Patent: December 12, 2006
    Assignee: Bayer Aktiengesellschaft
    Inventors: Stefan Grabowski, Volker Wege, Rüdiger Musch, Knut Panskus, Thiemo Marx
  • Patent number: 7148374
    Abstract: The present invention relates to novel blocked, elimination-free polyurethane (PUR) crosslinking agents, to a process for their preparation and to their use as starting components for the production of polyurethane plastics, especially as crosslinking agents for thermally crosslinkable powder coatings.
    Type: Grant
    Filed: December 17, 2003
    Date of Patent: December 12, 2006
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dorota Greszta-Franz, Christoph Gürtler, Reinhard Halpaap, Michael Schelhaas, Michael Grahl